Aura Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held on June 15, 2022. Aura Biosciences, Inc. is a Delaware corporation with its principal executive offices in Cambridge, Massachusetts. The company is classified as an emerging growth company and its common stock trades on The Nasdaq Global Market under the symbol AURA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results rather than financial performance.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting. There were 29,222,296 shares entitled to vote, with 19,091,391 shares present or represented by proxy.
Proposal 1: Election of Directors
Three Class I director nominees were elected to serve until the 2025 Annual Meeting. The voting results were as follows:
| Director Nominee | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| Elisabet de los Pinos, Ph.D. | 18,503,362 | 53,765 | 534,264 |
| Giovanni Mariggi, Ph.D. | 18,450,731 | 106,396 | 534,264 |
| Raj Parekh, Ph.D. | 18,434,446 | 122,681 | 534,264 |
Proposal 2: Ratification of Accounting Firm
Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
| Votes For | Votes Against | Abstentions |
|---|---|---|
| 19,088,824 | 604 | 1,963 |
There were zero broker non-votes regarding this proposal.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to reporting the outcomes of the shareholder vote.
Key Facts for Investor Verification
- Verify the tenure of the newly elected directors (Elisabet de los Pinos, Giovanni Mariggi, and Raj Parekh) through the 2025 Annual Meeting.
- Confirm the engagement of Ernst & Young LLP for the 2022 fiscal year audit.
- Note the significant number of broker non-votes (534,264) on the director election, which may indicate shares held by brokers without voting instructions on non-routine matters.
- Review the definitive proxy statement filed on April 28, 2022, for detailed biographies of the directors and further context on the proposals.